chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt. states that after receiving the 2nd dose of Moderna 12/08/2021, started experiencing symptoms 12/10/2021 of nausea, light headedness, and  itchiness (left) at the injection site. No noted Primary visit/communications. Still experiencing symptoms.
Patient's arm red, swollen and raised at the injection site. Area of redness is approximately the size of a quarter. Pt said she noticed it on 5/3/21 and denies itching or pain.  Recommended ice, antihistamine and acetaminophen or ibuprofen if needed. Recommended follow up with prescriber if it worsens.
Information has been received from a consumer concerning her son who had an unspecified allergic reaction to a tetanus shot who on an unspecified date was vaccinated with a dose of MMR II. Subsequently, the patient had a reaction to this vaccine. At the time of the report, the patient's outcome was unknown. No further information is available.
Myalgias, fatigue, chills for 48 hours, left axillary lymphadenopathy unresolved at 72 hours
Patient's daughter was reporting. Patient previously had Johnson and Johnson COVID-19 vaccine and presented to the pharmacy for a flu shot. A Moderna COVID-19 vaccine was administered by mistake. The pharmacist contacted the patient to notify her of the mistake, and the patient went to the ER on 9/13/2021 to be assessed. She will see her primary healthcare provider on 9/17/2021.
Pain on their knees; Fever; Body aches; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pain on their knees), PYREXIA (Fever) and MYALGIA (Body aches) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Pain on their knees), PYREXIA (Fever) and MYALGIA (Body aches). At the time of the report, ARTHRALGIA (Pain on their knees), PYREXIA (Fever) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
Information has been received from a physician concerning a "young child" who was vaccinated with a dose of PROQUAD (Merck). Subsequently, within 24 hours after receiving the vaccination, the patient experienced a seizure. The outcome was reported as recovered. It was unspecified if medical attention was sought. No product quality complaint was involved. Follow-up information has been received concerning a 27-month-old male who on 17-Oct-2007 was vaccinated with a dose of MMR II (lot # "0867F") previously reported as PROQUAD (Merck). Secondary suspect vaccination included a dose of PEDVAXHIB (lot # 02789, manufacturer unknown). Concomitant medications included a dose of DTAP and INFLUENZA virus vaccine (unspecified). On 18-Oct-2007, the patient had fever, chills, lethargy and a seizure and was sent to the ER. The patient was given two doses of ATIVAN in the ER to stop the seizure. The patient's discharge diagnosis included atypical febrile seizure, upper respiratory seizure, right otitis media, and developmental delay. The patient was given antibiotics for the otitis media. Upon internal review, seizure was considered to be an other important medical event. Additional information has been requested.
Within about 5 minutes of receiving the vaccine became sweaty, clammy, pale and vision became very blurred.  This lasted about 10 minutes before symptoms subsided.
A non-serious spontaneous report of administration of expired FLUMIST was received from a nurse concerning a 28-year-old female. Neither medical history nor concomitant medications were reported. On 26-Jan-2009, the patient received expired FLUMIST vaccine. The vaccine had an expiration date of 12-Jan-2009. As of 18-Mar-2009, there was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Based on the results of the investigation, the root cause for the medication errors were caused by 1) customers not discarding product from previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the product expired. Follow-up information was received on 12-May-2009: Product Complaint Investigation results.
1 lymph node size of 1" in diameter at the Left Axilla, non tender, mobile no redness.
Patient reported receiving the vaccine mid-afternoon, then waking up at midnight feeling feverish. His wife said he had chills and was hot to the touch. They did not check his temperature. He felt fine again by 7am the next morning.
On 7/31/01, telephone call reported, red and warm area on right upper arm (1st report per mom). On 8/1/01, follow-up telephone call, pt has a red circle around point of injection with solid bumps (small), 1 1/2" around from back of child's right arm. Pt is acting good. No temperature and improving daily.
Symptoms included aching, feeling nauseous, fever 101.7F oral x1.
About 3 hours after the vaccine I began to get very nauseous, and began to vomit. The nausea and vomiting did not subside until about 5 hours later.
For three days after the vaccine I would alternate between chills and hot flashes. I also had body aches all over. I was lethargic, just drained of energy. I did not have a fever at anytime. Three days after the vaccine I developed a scratchy throat and cough.
Patient is a 84 Y  male with history of advanced dementia, celiac disease, type 2 diabetes (on metformin, glipizide and NPH), history of metastatic melanoma, hypertension presented for fatigue and found to be hyperglycemic (BS >500) and COVID +. Patient's hyperglycemia was corrected with resuming his home medications and insulin. As for COVID, patient did not have any respiratory symptoms and can be considered asymptomatic. Evaluated by PT and patient demonstrated good mobility. Stable for discharge home on current home meds and follow up for dementia evaluation as outpatient.
shoulder pain radiating to chest; arm and shoulder pain which radiates from the injection site; arm and shoulder pain which radiates from the injection site; arm and shoulder pain which radiates; Vaccine Administered at Inappropriate Site; This case was reported by a consumer via call center representative and described the occurrence of chest pain in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced chest pain, pain in arm, shoulder pain, injection site pain and vaccine administered at inappropriate site. The patient was treated with ambiguous medication nos (Cortisone (Nos)). On an unknown date, the outcome of the chest pain, pain in arm, shoulder pain and vaccine administered at inappropriate site were unknown and the outcome of the injection site pain was recovering/resolving.   It was unknown if the reporter considered the chest pain, pain in arm, shoulder pain and injection site pain to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient's wife. The age at vaccination was not reported. The reporter reported that, after vaccination with dose of Shingrix had arm and shoulder pain which radiates from the injection site. The symptoms have only slightly improved. The reporter stated that, the injection site was very high on the upper right arm and may have gone into the shoulder bursa sac, which led to vaccine administered at inappropriate site. The patient consulted with an orthopedic specialist and a cortisone injection was given in the shoulder. The  reporter consented to follow up. This case has been linked with case US2019229382, reported by same reporter.
I began to have a fever 18 hours after receiving the vaccine. Then when I woke up approximately 24 hours after receiving the vaccine, I felt severe sinus pressure, headache, light sensitivity, body aches, slight nausea, continued fever cycling, and lethargy. These symptoms began to resolve 24 hours after they started. These were the exact same symptoms that I experienced when I had Covid-19.
Weekness; headaches; fevers; muscle achea; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 28Feb2021 at 10:30(at the age of 74-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. Concomitant medication was not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on an unknown date as a single dose for COVID-19 immunisation. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Mar2021, the patient experienced weakness, headaches, fevers and muscle ache. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events weakness, headaches, fevers and muscle ache were not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
About 8 days after vaccine I developed a large bright red area about 5-6? x 3-4? located about 3? below injection site. Also the injection site got red the size of quarter. Itchy, swollen, tender to touch. I didn?t have any reaction after injection until this happened. Went away after a few days. A bit discolored. I do have pictures it you want.
pt recv vax MAY96 or JUN96 & w/in 24hr of vax pt exp 1 sz;
the patient is having muscle pain and joint pain around his knee area.  He also has redness at the injection site and swelling.   Patient will follow up with doctor next week in person if not getting better.  Patient has contacted his physician.
Information has been received from a consumer, refers to her daughter, 18 years old female patient. In 1995, the patient was vaccinated with VARIVAX (merck) injection, (lot number not provided) at the age of 12 year old. No other co-suspects were reported. No concomitant medications were reported. Then later was diagnosed with a case of chickenpox in 2001. Her daughter was just recently tested and found to have no antibodies against the chicken pox virus in her system, so she received another dose of the vaccine as an adult. The outcome of the events of the patient was tested and found to have no antibodies against the chickenpox virus in her system and chickenpox was unknown. The relatedness for the patient was tested and found to have no antibodies against the chickenpox virus in her system and chickenpox was unknown for VARIVAX (Merck). Additional information has been requested.
Sat 1/9/2010 became achy and dizzy. Could not get out of bed next morning. Very weak. Felt cold/hot fever. Got out of bed Tues to lay on couch. Not fully recovered till Wednesday night.
Early onset dizziness x3days, then fatigue, loss of coordination, loss of balance and equilibrium. Fine motor skills affected also (typing and writing)...things I normally did with ease. Unable to work or drive for several weeks. Saw PCP and neurologist. Had CT brain, labs, EKG, and MRI brain all negative. Did PT for 4 weeks. Unable to get a diagnosis. Tried meclizine and 5 days of tapered steroids...neither helped symptoms. Slowly improving, but not 100% yet. Was a very healthy, active 56 year old who NEVER got sick, not got the flu shot until employer required it.
-Itchy red, raised spots on trunk, then arms, move around to different areas - Lasts 1 hour - Tends to happen mostly in the evenings, around 5pm - Current tx: cetirizine 10 mg once daily
Patient received 1st dose Moderna on 4/23/21, scheduled to come back for second dose on 5/21/21, however patient came in on 4/30/21 with spouse and received 2nd dose. Staff error in reviewing card and during discussion with patient. Staff advised RN of 2nd dose being 7 days after first dose. RN advised patient, made aware, patient shared he was not concerned he will be fine. RN kept patient for 30 minute observation, advised to contact PCP or ER for severe side effects of vaccine.  Unable to complete follow-up with patient as his phone number is not valid.
Patient was due for Hep A vaccine and was given Hep B in error.  No adverse effects reported.
Dose was administered 1 hour after dose expiration.  Dose expired at 1425 and he was given an expired dose of Pfizer Covid Vaccine at 1530.  Contacted Pfizer as well as Dept. of Health.  Pfizer had no recommendations to repeat the dose.  The state contacted CDC and responded with "Here is what current guidance states:     Dose administered after improper storage and handling (e.g., temperature excursion, more than allowed time after first vial puncture) Contact the manufacturer for guidance. If the manufacturer provides information supporting that the dose should be repeated, the repeated dose may be given immediately (no minimum interval) in the opposite arm.   Pfizer does not give guidance to repeat dose so dose was not repeated.
This case was reported by a nurse via sales rep and described the occurrence of fever in an adult female patient who received FLULAVAL QUADRIVALENT 2018-2019 season for prophylaxis. On an unknown date, the patient received FLULAVAL QUADRIVALENT 2018-2019 season at an unknown dose. On an unknown date, less than a year after receiving FLULAVAL QUADRIVALENT 2018-2019 season, the patient experienced fever, local swelling, skin warm and localized erythema. On an unknown date, the outcome of the fever, local swelling, skin warm and localized erythema were recovered/resolved. It was unknown if the reporter considered the fever, local swelling, skin warm and localized erythema to be related to FLULAVAL QUADRIVALENT 2018-2019 season. Additional details were provided as follows: The age at the vaccination was not reported. The patient experienced red lump the size of a golf ball, swollen and fever or hot for 3 to 4 days. The reporter was agree to follow up from GlaxoSmithKline.
Patient states she broke out in hives from head to toe on 1/21/2021 after receiving her 1st Covid vaccine on 1/06/2021. States they are very itchy and spreading and Benadryl doesn't help. Referred to Urgent Care where she was treated with Prednisone and it is now clearing up. She does NOT want to receive the second dose of the vaccine.
Weeks after vaccination my brain was fogging; everything was stiff; no concentration; fatigue. So I went to doctor and he ran a blood test and he said that my lupus has came back. I don't blame that vaccination.
Rec'd vaccine on Monday- by Wed of same week severe reaction about 6 inches long around injection site. Red, warm to touch, red extremely inflamed and painful.
Hot to touch injection site; Really Red injection site; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Hot to touch injection site) and INJECTION SITE ERYTHEMA (Really Red injection site) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 12L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history).    On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced FEELING HOT (Hot to touch injection site) and INJECTION SITE ERYTHEMA (Really Red injection site). At the time of the report, FEELING HOT (Hot to touch injection site) and INJECTION SITE ERYTHEMA (Really Red injection site) outcome was unknown.            No relevant concomitant medications were reported.  Treatment details included Ice.  Action taken with mRNA-1273 in response to the events was not applicable.
Patient has a large local inflammatory reaction with warmth & erythema on the right upper arm at area of vaccinations 2 days ago. Recommend benadryl q4-6hrs x 24 hrs, ice to area and possible start of Keflex if concern for infection arises over the next 24 hours
About 1-2 weeks after receiving each vaccine, I started to experience respiratory distress with severe wheezing. The worst episode was after the 2nd shot where I was short of breath, wheezing despite receiving multiple DuoNeb treatments. Chest X-ray was negative and I have never had asthma or even  wheezed in my life even with other illnesses. I was tachycardic up to 130s sustained, at one point up to 140. Oxygen saturation at its worst dropped to the high 80s. The symptoms lasted about 1 week at its worst, but would have lingering wheezes intermittently. These events happened after both shots, the first and second; however the second shot was more severe to the point where I needed to miss work because I could not breathe. I was given 10 days of dexamethasone, albuterol inhaler PRN, ipratropium inhaler
Arm was swollen for a day or two; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm was swollen for a day or two) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021A21A and 048A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced PERIPHERAL SWELLING (Arm was swollen for a day or two). At the time of the report, PERIPHERAL SWELLING (Arm was swollen for a day or two) had resolved.            No concomitant medications were provided.  No treatment medications were reported.   This case was linked to MOD-2021-410054, MOD-2021-410095 (Patient Link).
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. Medical history, concurrent conditions and concomitant medications were not reported. On 13-JAN-2014, the patient was vaccinated with a dose of improperly stored PEDVAXHIB (lot number# J005672, Expiry date: 05-DEC-2015) (dose and route were not reported). No adverse experiences were reported. This is one of several reprots received from the same reporter. Additional information has been requested.
Received shot left arm at pharmacy at 1300 on July 9th by pharm. on duty. Next day had redness swelling, headache, low grade temp to 100 degrees, aches. On Wed had more swelling and pain in the lymph node areas. It took at least 5-6 days for all of this to go away. Took BENADRYL and topical BENADRYL for pain relief.
t103, crying for hrs & hrs, inconsolable;rash to rt leg w/swelling;Advil given by mouth;cold compress to leg;sent home w/instructions
Got shot Thursday May 6th, ran 103 degree temp  Friday, Saturday had temp of 100 and felt like was going to pass out once around lunch, then a dizzy spell. Sunday morning (6:00 am) presented with chest pain for about ten minutes that subsided. Sunday night/ Monday morning at approximately midnight (12:00 am) presented again with chest pain that continued as we sought medical attention from local fire department, to which an ambulance was called, meds were given and diagnosis was heart attack from labs drawn at hospital. Took him back for a heart cath and there was no blockage. From everything I was told they couldn't figure out what caused the chest pain.  He spent 2 days in CCU. He discharged Wednesday the 12th of May. He is now on Plavix, Coreg, a low dose aspirin, and Atorvastatin.
Information has been received from a registered nurse concerning a 43 year old African American female with no allergies or medical history who on 9/10/03 was vaccinated with a dose of hepatitis A virus vaccine inactivated. There was no illness at the time of vaccination. On 11/1/03, the patient had a lab drawn, which was negative for HAV AB. The patient was noted to be otherwise healthy and was manifesting no other signs or symptoms. Unspecified medical attention was sought. A product quality complaint was not involved. Follow up information was received from the registered nurse which indicated that the lab report was supplied by the patient through her primary care provider. The nurse indicated that she did not administer the vaccine and that it was given at another location, possibly her primary care physician. One month after vaccination, the patient had routine blood work done for an annual examination. The patient requested the hepatitis A antibody titer because she was traveling overseas and wanted to be sure she was protected. The patient called the reporters office to receive immune globulin because she was told her lab work came back negative. The patient brought the lab report to the reporter's office. The nurse indicated that the lab report was read to the advising physician and verified that it was a negative result. It was decided that the patient would benefit from both immune globulin and hepatitis A vaccination. Additional information has been requested.
sleepy; tired; grandchildren who are below 18 years of age; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleepy), FATIGUE (tired) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (grandchildren who are below 18 years of age) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (sleepy), FATIGUE (tired) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (grandchildren who are below 18 years of age). At the time of the report, SOMNOLENCE (sleepy), FATIGUE (tired) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (grandchildren who are below 18 years of age) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       Reporter mentioned that 3 of her grandchildren are below 18 years of age. Concomitant medications was not provided by the reporter. Treatment information was not provided.   Reporter did not allow further contact
Pt recv vax on 10/29/98; on 11/22/98 pt exp groaning stomach, stomach pain, diarrhea x 2 wk, muscle aches x 3-4 days, fever, headache & malaise
Increased pain in left arm, increased fatigue, headache, fever 102 F, nasal and chest congestion, malaise, nausea, vomiting, new onset  palpitations, tachycardia, chest pain, chest tightness and increased shortness of breath with any activity and New onset renal insufficiency.